The global infection control market is on an upward trajectory and forecasts are abuzz with predictions of substantial growth. The market, which registered revenue worth $51.0 billion in 2024, is set to escalate to a staggering $69.2 billion by 2029, showcasing a compound annual growth rate (CAGR) of 6.3% from 2024 to 2029, as per a recent report published by MarketsandMarkets™.
A confluence of factors is fueling this impressive growth trajectory. Primarily, there is a renewed emphasis on food sterilization across the globe, driven by increasing concerns surrounding food safety and potential contamination. Moreover, various sectors, such as healthcare, hospitality, and manufacturing, have escalated their focus on disinfection. This surge in demand for sterilization and disinfection is primarily attributed to the heightened public awareness surrounding infectious disease prevention, particularly in the context of the prevailing global health challenges.
Given this amplifying focus on infection control across multiple industries, as a means to safeguard public health, the market for disinfectants, sterilization products, and associated services, is slated for sustained growth in the coming years.
The infection control market, in detailed segmentation, is classified based on product & services into sterilization products & services, consumables & accessories, cleaning & disinfection products, protective barriers, endoscope reprocessing products and other infection control products. Additionally, the market is also segmented based on the end-user demographic, which includes hospitals & clinics, medical device companies, pharmaceutical companies, the life science industry, the food industry, among other sectors.
The concerted efforts of various governments in establishing rigid regulations for sterilization and disinfection form a firm foundation for this market’s growth. North America, due to its emphasis on healthy living and disease prevention, has emerged as the largest contributor to the infection control market.
On the competitive front, key players in the infection control market arena include STERIS plc, Getinge AB, Ecolab, Inc., 3M Company, and Advanced Sterilization Products, among others, whose strategic moves such as acquisitions, product launches, expansions, and partnerships continue to shape the competitive landscape.
Source: https://www.investorsobserver.com/news/qm-pr/7282917721978590